Patents Assigned to QINGDAO CHENLAND BIOLOGICAL TECHNOLOGY CO., LTD.
  • Publication number: 20220339235
    Abstract: A traditional Chinese medicine compound composition with effect of improving male sexual function and its application are disclosed. The disclosure prepares the traditional Chinese medicine compound composition by compounding Semen Allii Tuberosi with Radix Morindae Officinalis, Epimedii Folium, Cistanche deserticola Ma and Semen Cuscutae. The traditional Chinese medicine compound composition has a good effect on improving the sexual function of kidney Yang deficiency model mice. While improving sexual function, it can improve the abundance of spermatogenic cells in testicular seminiferous tubules, ensure that spermatogenic cells can continuously produce new sperm, and improve the number and morphology of sperm in the lumen. Moreover, the disclosed traditional Chinese medicine compound composition can be used as a raw material of dietary supplement or health food for the male population with low sexual function and easy fatigue.
    Type: Application
    Filed: July 7, 2022
    Publication date: October 27, 2022
    Applicants: Chenland Nutritionals Inc., QINGDAO CHENLAND BIOLOGICAL TECHNOLOGY CO., LTD.
    Inventors: Shengcan Zou, Jie Wang, Xin Li, Li Li, Shanglong Wang, Yuanyuan Wang, Xuena Song
  • Publication number: 20220280431
    Abstract: A curcumin complex, a preparation method therefor and a detection method therefor, the curcumin complex comprising a solid complex formed by grinding auxiliary material and curcumin, the auxiliary material comprising Soluplus, poloxamer 407, or poloxamer 188; when the auxiliary material comprises the Soluplus, the mass ratio of the curcumin to the Soluplus is 1:8-10; and when the auxiliary material comprises the poloxamer 407 or poloxamer 188, the mass ratio of the curcumin to the poloxamer 407 is 1:0.4-0.6, and the mass ratio of the curcumin to the poloxamer 188 is 1:0.4-0.6. Also disclosed is a preparation method for a curcumin complex. The curcumin complex has high bioavailability and a simple prescription process; in addition, the crystal form of the curcumin is not changed, and not only is quality control more complete and reliable, but costs are also lower, and large-scale production is facilitated.
    Type: Application
    Filed: December 25, 2020
    Publication date: September 8, 2022
    Applicants: CHENLAND NUTRITIONALS, INC., QINGDAO CHENLAND BIOLOGICAL TECHNOLOGY CO., LTD.
    Inventors: Shengcan ZOU, Min HAN, Jiancheng ZONG, Lei ZONG, Shanglong WANG, Xin LI